abstract |
A method for treating smoking-related bone loss which comprises administering to a human in need thereof a pharmaceutically-effective amount of a compound having the formulan n wherein R 1 and R 3 are independently hydrogen, C 1 -C 4 alkyl, -CO-(C 1 -C 6 alkyl), or -CH 2 Ar, -CO-Ar, wherein Ar is phenyl or substituted phenyl; n R 2 is selected from the group consisting of pyrrolidine, hexamethylenemino, and piperidino; or a pharmaceutically-acceptable salt thereof. |